Evidence that the epidermal growth factor receptor on host cells confers reovirus infection efficiency
- PMID: 8212574
- DOI: 10.1006/viro.1993.1602
Evidence that the epidermal growth factor receptor on host cells confers reovirus infection efficiency
Abstract
Reovirus binds to multiple sialoglycoproteins on the host cell surface. In an attempt to probe additional specific determinants that dictate host cell susceptibility to reovirus infection, we found that two mouse cell lines (NR6 and B82) previously shown to express no endogenous epidermal growth factor (EGF) receptors were relatively resistant to reovirus infection, whereas the same cell lines transfected with the gene encoding the EGF receptor manifested significantly higher susceptibility as determined by induction of cytopathic effects, viral protein synthesis, and plaque titration. This enhancement of infection efficiency requires a functional EGF receptor since it was not observed in cells expressing a mutated (kinase-inactive) EGF receptor. The observed difference in infection efficiency is not due to differences in virus binding or internalization. These studies suggest that the reovirus infection process is closely coupled to the EGF receptor-mediated cell signal transduction pathway.
Similar articles
-
Recognition of the epidermal growth factor receptor by reovirus.Virology. 1993 Nov;197(1):412-4. doi: 10.1006/viro.1993.1603. Virology. 1993. PMID: 8212575
-
Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors.EMBO J. 1997 Sep 15;16(18):5608-17. doi: 10.1093/emboj/16.18.5608. EMBO J. 1997. PMID: 9312020 Free PMC article.
-
Osteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways.Oncogene. 2003 Feb 27;22(8):1198-205. doi: 10.1038/sj.onc.1206209. Oncogene. 2003. PMID: 12606946
-
Reoviruses and the host cell.Trends Microbiol. 2001 Nov;9(11):560-4. doi: 10.1016/s0966-842x(01)02103-5. Trends Microbiol. 2001. PMID: 11825717 Review.
-
Cellular genetics of host susceptibility and resistance to virus infection.Crit Rev Eukaryot Gene Expr. 2006;16(2):155-70. doi: 10.1615/critreveukargeneexpr.v16.i2.40. Crit Rev Eukaryot Gene Expr. 2006. PMID: 16749895 Review.
Cited by
-
The oncolytic virus, pelareorep, as a novel anticancer agent: a review.Invest New Drugs. 2015 Jun;33(3):761-74. doi: 10.1007/s10637-015-0216-8. Epub 2015 Feb 19. Invest New Drugs. 2015. PMID: 25693885 Review.
-
Reovirus oncolysis: the Ras/RalGEF/p38 pathway dictates host cell permissiveness to reovirus infection.Proc Natl Acad Sci U S A. 2004 Jul 27;101(30):11099-104. doi: 10.1073/pnas.0404310101. Epub 2004 Jul 19. Proc Natl Acad Sci U S A. 2004. PMID: 15263068 Free PMC article.
-
Reovirus as a novel oncolytic agent.J Clin Invest. 2000 Apr;105(8):1035-8. doi: 10.1172/JCI9871. J Clin Invest. 2000. PMID: 10772645 Free PMC article. No abstract available.
-
The viral tropism of two distinct oncolytic viruses, reovirus and myxoma virus, is modulated by cellular tumor suppressor gene status.Oncogene. 2010 Jul 8;29(27):3990-6. doi: 10.1038/onc.2010.137. Epub 2010 May 17. Oncogene. 2010. PMID: 20473328 Free PMC article.
-
The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus.EMBO J. 1998 Jun 15;17(12):3351-62. doi: 10.1093/emboj/17.12.3351. EMBO J. 1998. PMID: 9628872 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials